Gabather AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Gabather AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8127
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Gabather AB (Gabather) is a developer of new drug candidates for the treatment of central nervous system diseases. The company spans its expertise in the development of anti-psychotics, anti-depressants and anxiolytics, analgesics, and cognition-enhancing treatments. It offers drug candidates in form of small molecules that integrate with the Gaba receptor complex in the brain. The company targets diseases include learning, cognition, sleep regulation, pain, anxiety, epilepsy, muscular tension and addiction, among others. It serves in the US, Canada, China and India. Gabather is headquartered in Malmo, Sweden.

Gabather AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gabather AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gabather AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gabather AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gabather AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Gabather Enters into Agreement with Smerud Medical Research International and Clinical Research Services Turku 10
Gabather Enters into Research Agreement with UNSW 11
Equity Offering 12
Gabather Raises USD3.2 Million in Rights Offering of Units 12
Gabather to Raise up to USD4 Million in Rights Offering of Shares 13
Gabather Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 14
Gabather Raises USD1 Million in Offering of Units 15
Gabather AB – Key Competitors 16
Gabather AB – Key Employees 17
Gabather AB – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Gabather AB, Pharmaceuticals & Healthcare, Key Facts 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gabather AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gabather AB, Deals By Therapy Area, 2012 to YTD 2018 8
Gabather AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gabather Enters into Agreement with Smerud Medical Research International and Clinical Research Services Turku 10
Gabather Enters into Research Agreement with UNSW 11
Gabather Raises USD3.2 Million in Rights Offering of Units 12
Gabather to Raise up to USD4 Million in Rights Offering of Shares 13
Gabather Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 14
Gabather Raises USD1 Million in Offering of Units 15
Gabather AB, Key Competitors 16
Gabather AB, Key Employees 17

List of Figures
Gabather AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gabather AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gabather AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Gabather AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Companhia de Transmissao de Energia Eletrica Paulista (TRPL4):企業の財務・戦略的SWOT分析
    Summary Companhia de Transmissao de Energia Eletrica Paulista (CTEEP) a subsidiary of Interconexion Electrica SA ESP, is an electric utility service provider that produces and distributes electricity. The utility owns and operates power generation plants and transmission lines and supplies electrici …
  • Pinsent Masons LLP:企業の戦略的SWOT分析
    Pinsent Masons LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Jaya Tiasa Holdings Berhad (JTIASA):企業の財務・戦略的SWOT分析
    Jaya Tiasa Holdings Berhad (JTIASA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Entasis Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Entasis Therapeutics Inc (Entasis) is a drug development company that discovers and develops anti-infective therapies for drug-resistant bacterial infections. The company’s pipeline products include ETX2514, ETX0282, ETX0914 and Zoliflodacin. Its ETX2514 is a potent inhibitor of class A, C, …
  • Topaz Energy and Marine Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Topaz Energy and Marine Ltd (Topaz), a subsidiary of Renaissance Services SAOG, is an oil and gas company that offers offshore support vessels and marine solutions. The company's services include platform supply, anchor handling, emergency recovery and response and crew transfer. It operates …
  • Novartis AG:企業のM&A・事業提携・投資動向
    Novartis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novartis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Miromatrix Medical Inc:製品パイプライン分析
    Summary Miromatrix Medical Inc (Miromatrix Medical) is a life science company that develops regenerative medicines. The company offers MIRODERM biologic wound matrix, MIROMESH biologic matrix, liver function restoration, kidney products, diabetes treatment and cortical strut. It creates biological r …
  • United States Postal Service:企業の戦略・SWOT・財務分析
    United States Postal Service - Strategy, SWOT and Corporate Finance Report Summary United States Postal Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Idexx Laboratories Inc (IDXX)-製薬・医療分野:企業M&A・提携分析
    Summary Idexx Laboratories Inc (IDEXX) is a diagnostics company. It develops, manufactures and distributes products and services for small animals and livestock. The company offers veterinary reference laboratory diagnostics and consulting services, point-of-care veterinary diagnostic products, micr …
  • Wellcome Trust:企業のM&A・事業提携・投資動向
    Wellcome Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wellcome Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Ortivus AB (ORTI B):企業の財務・戦略的SWOT分析
    Summary Ortivus AB (Ortivus) is a supplier of mobile solutions for emergency medical care. The company develops and offers cardiology, and mobile monitoring and communication solutions. Its products include MobiMed Smart, CoroNet, excense heart record system and excense decision support healthcare s …
  • QuadGraphics, Inc. (QUAD):企業の財務・戦略的SWOT分析
    QuadGraphics, Inc. (QUAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Northam Platinum Limited:企業の戦略・SWOT・財務情報
    Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report Summary Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • First Busey Corp:企業の戦略・SWOT・財務分析
    First Busey Corp - Strategy, SWOT and Corporate Finance Report Summary First Busey Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Organogenesis Inc-医療機器分野:企業M&A・提携分析
    Summary Organogenesis Inc (Organogenesis) is a regenerative medicine company that operates in the areas of bioactive wound healing and soft tissue regeneration. The company’s products include apligraf and dermagraft. Its dermagraft is used for the treatment of full-thickness diabetic foot ulcers. Or …
  • Daepyung Co., Ltd.:企業の戦略・SWOT・財務情報
    Daepyung Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daepyung Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Endesa SA (ELE):電力:M&Aディール及び事業提携情報
    Summary Endesa SA (Endesa), a subsidiary of Enel SpA, is an electric utility. It generates, distributes, and sells electricity. The company produces electricity in hydro, thermal, nuclear, combined cycle, and renewable and cogeneration plants. Endesa also supplies electricity and gas, and provides o …
  • AdvantEdge Healthcare Solutions Inc:医療機器:M&Aディール及び事業提携情報
    Summary AdvantEdge Healthcare Solutions Inc (AdvantEdge) is a healthcare service provider that offers medical billing, coding and revenue cycle management solutions. The center’s solutions include medical billing, coding, reporting, dashboards and business intelligence, consulting and practice manag …
  • Banca Transilvania S.A.:企業の戦略・SWOT・財務情報
    Banca Transilvania S.A. - Strategy, SWOT and Corporate Finance Report Summary Banca Transilvania S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Masterflex SE (MZX):企業の財務・戦略的SWOT分析
    Summary Masterflex SE (Masterflex), formerly Masterflex AG, is a manufacturer and supplier of spiral hoses. The company manufactures and markets high-tech spiral hoses. It offers hoses and connecting systems such as abrasion-resistant suction and transport hoses made from PU, suction and transport h …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆